Gene therapy for chronic pain gets first test in people

This week, University of Michigan scientists will begin a phase 1 clinical trial for the treatment of cancer-related pain, using a novel gene transfer vector injected into the skin to deliver a pain-relieving gene to the nervous system.

If you want to include this story in your blog, copy and paste this formatted text: